|
Re: prognosis of her2+er+ breast cancer discussed
Unless I misunderstand...this one is studied patients that did not receive Herceptin (I assume that's what's meant by "...unselected population of breast cancer patients who did not receive HER2-targeted therapy.")
I thought that was already an established fact that Her2 positive automatically made you a candidate for Herceptin because of its agressive nature (therefore no surprise that ER+/HER2- had better rates than ER+/HER2+ without Herceptin therapy). Not sure I understand this abstract correctly at all.
__________________
4/09 suspicious lump in left breast
5/09 biopsi lead to diagnosis ER/PR -
Her2+.Grade 3,full masectomy left breast,sentinel nodes clear,Stage 1
6/09 Adriamycin + Cytoxan 4 treatments (every 3 weeks) followed by Taxol + Herceptin, 1 treatment weekly for 12 weeks, followed by Herceptin for 40 weeks
MRI Brain 4/10 clear
CT Body 4/10 clear
PET Body 2/11 clear
|